BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32182257)

  • 1. AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice.
    Choi SK; Kwon Y; Byeon S; Haam CE; Lee YH
    PLoS One; 2020; 15(3):e0230227. PubMed ID: 32182257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
    Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
    J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.
    Belmadani S; Palen DI; Gonzalez-Villalobos RA; Boulares HA; Matrougui K
    Diabetes; 2008 Jun; 57(6):1629-37. PubMed ID: 18319304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of autophagy improves vascular function in the mesenteric arteries of type 2 diabetic mice.
    Choi SK; Kwon Y; Byeon S; Lee YH
    Exp Physiol; 2020 Jan; 105(1):192-200. PubMed ID: 31736185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin Receptor Agonist, AdipoRon, Causes Vasorelaxation Predominantly Via a Direct Smooth Muscle Action.
    Hong K; Lee S; Li R; Yang Y; Tanner MA; Wu J; Hill MA
    Microcirculation; 2016 Apr; 23(3):207-20. PubMed ID: 26728950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intervention effects of oral active AdipoRon on liver oxidative stress in type 2 diabetic mice].
    Xiao M; Qu XH; Chen H; Cai QJ; Xie KJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Feb; 33(2):124-127. PubMed ID: 29931918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.
    Schmid PM; Resch M; Schach C; Birner C; Riegger GA; Luchner A; Endemann DH
    Cardiovasc Diabetol; 2013 Mar; 12():46. PubMed ID: 23497197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
    Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
    Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity.
    Okada-Iwabu M; Yamauchi T; Iwabu M; Honma T; Hamagami K; Matsuda K; Yamaguchi M; Tanabe H; Kimura-Someya T; Shirouzu M; Ogata H; Tokuyama K; Ueki K; Nagano T; Tanaka A; Yokoyama S; Kadowaki T
    Nature; 2013 Nov; 503(7477):493-9. PubMed ID: 24172895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase.
    Solini A; Rossi C; Duranti E; Taddei S; Natali A; Virdis A
    Vascul Pharmacol; 2016 Jan; 76():62-71. PubMed ID: 26455387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries.
    Lagaud GJ; Masih-Khan E; Kai S; van Breemen C; Dubé GP
    J Vasc Res; 2001; 38(6):578-89. PubMed ID: 11740157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin receptor agonist ameliorates cardiac lipotoxicity via enhancing ceramide metabolism in type 2 diabetic mice.
    Kim Y; Lim JH; Kim EN; Hong YA; Park HJ; Chung S; Choi BS; Kim YS; Park JY; Kim HW; Park CW
    Cell Death Dis; 2022 Mar; 13(3):282. PubMed ID: 35351872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoring diabetes-induced autophagic flux arrest in ischemic/reperfused heart by ADIPOR (adiponectin receptor) activation involves both AMPK-dependent and AMPK-independent signaling.
    Wang Y; Liang B; Lau WB; Du Y; Guo R; Yan Z; Gan L; Yan W; Zhao J; Gao E; Koch W; Ma XL
    Autophagy; 2017; 13(11):1855-1869. PubMed ID: 28825851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endothelial calcium signaling is responsible for the defective dilation of mesenteric resistance arteries from db/db mice to acetylcholine.
    Chen H; Kold-Petersen H; Laher I; Simonsen U; Aalkjaer C
    Eur J Pharmacol; 2015 Nov; 767():17-23. PubMed ID: 26420355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability.
    Pannirselvam M; Verma S; Anderson TJ; Triggle CR
    Br J Pharmacol; 2002 May; 136(2):255-63. PubMed ID: 12010774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of adiponectin receptors has negative impact on muscle mass in C2C12 myotubes and fast-type mouse skeletal muscle.
    Ito R; Higa M; Goto A; Aoshima M; Ikuta A; Ohashi K; Yokoyama S; Ohno Y; Egawa T; Miyata H; Goto K
    PLoS One; 2018; 13(10):e0205645. PubMed ID: 30308063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes.
    Nacci C; Leo V; De Benedictis L; Potenza MA; Sgarra L; De Salvia MA; Quon MJ; Montagnani M
    Vascul Pharmacol; 2016 Dec; 87():83-91. PubMed ID: 27565410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation.
    Yamamoto E; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Nako H; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):258-63. PubMed ID: 21059340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.